Anne M Traynor

Anne M Traynor

UNVERIFIED PROFILE

Are you Anne M Traynor?   Register this Author

Register author
Anne M Traynor

Anne M Traynor

Publications by authors named "Anne M Traynor"

Are you Anne M Traynor?   Register this Author

57Publications

1273Reads

49Profile Views

A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2016 Mar 20;77(3):527-38. Epub 2016 Jan 20.

Wisconsin Institute for Medical Research, University of Wisconsin Carbone Cancer Center, Room 7105, 1111 Highland Avenue, Madison, WI, 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-2958-1DOI Listing
March 2016

A phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer.

Cancer Chemother Pharmacol 2015 Aug 12;76(2):317-23. Epub 2015 Jun 12.

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-015-2783-y
Publisher Site
http://dx.doi.org/10.1007/s00280-015-2783-yDOI Listing
August 2015

Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observation.

Clin Lung Cancer 2014 Nov 24;15(6):433-40. Epub 2014 Jun 24.

Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.06.008DOI Listing
November 2014

Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy.

Head Neck 2014 Aug 27;36(8):1120-5. Epub 2013 Nov 27.

Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23419DOI Listing
August 2014

Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.

Sci Transl Med 2014 Jun;6(240):240ra75

Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA. Department of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3007646DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336181PMC
June 2014

Metastasis of primary lung carcinoma to the breast: a systematic review of the literature.

J Surg Res 2014 May 24;188(2):419-31. Epub 2014 Jan 24.

Department of Surgery, Clinical Science Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2014.01.024DOI Listing
May 2014

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.

J Clin Endocrinol Metab 2014 May 25;99(5):1687-93. Epub 2014 Feb 25.

Division of Medical Oncology (K.C.B., J.R.M., J.R., K.S., J.K.B., K.P.W., C.R.I., C.E.), Division of Biomedical Statistics and Informatics (V.J.S.), Division of Endocrinology (J.C.M., B.M., I.H., V.F.), Mayo Clinic, Rochester, Minnesota 55905; Division of Endocrinology (R.C.S.), Division of Medical Oncology (W.J.M., M.E.M., C.B.), Mayo Clinic Florida, Jacksonville, Florida 32224; Division of Medical Oncology (N.K.), Mayo Clinic Arizona, Scottsdale, Arizona 85259; Carbone Cancer Center (A.M.T.), University of Wisconsin, Madison Wisconsin 53705; Minnesota Oncology Hematology (P.J.F.), PA, Minneapolis, Minnesota 55407; National University Hospital (C.G.), Singapore 119228; and Cancer Therapy Evaluation Program (P.H.), National Cancer Institute, Bethesda, Maryland 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-3713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010705PMC
May 2014

Paired diagnostic and pharmacodynamic analysis of rare non-small cell lung cancer cells enabled by the VerIFAST platform.

Lab Chip 2014 Jan;14(1):99-105

Department of Biomedical Engineering, Wisconsin Institutes for Medical Research, University of Wisconsin-Madison, 1111 Highland Ave., Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c3lc50912eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897162PMC
January 2014

Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer.

J Clin Oncol 2013 Dec 21;31(34):4343-8. Epub 2013 Oct 21.

Donald M. Cannon, Pranshu Mohindra, Søren M. Bentzen, Anne M. Traynor, Richard J. Chappell, University of Wisconsin School of Medicine and Public Health, Madison, WI; Minesh P. Mehta, University of Maryland, Baltimore, MD; Jarrod B. Adkison, Southeast Alabama Medical Center, Dothan, AL; Deepak Khuntia, Varian Medical Systems, Palo Alto, CA; Wolfgang A. Tomé, Albert Einstein College of Medicine, Bronx, NY; George M. Cannon, Intermountain Medical Center, Salt Lake City, UT; Ranjini Tolakanahalli, Juravinski Cancer Center, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/31/34/4343.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.51.5353
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.5353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837093PMC
December 2013

A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.

Invest New Drugs 2013 Aug 21;31(4):943-8. Epub 2012 Dec 21.

University of Wisconsin Carbone Cancer Center and the University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, K6/548 CSC, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-012-9916-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199231PMC
August 2013

Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.

Lung Cancer 2013 Jul 28;81(1):138-41. Epub 2013 Apr 28.

Department of Medicine and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.03.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679338PMC
July 2013

Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximab.

Cancer Biol Ther 2013 Jun;14(6):481-91

Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Wisconsin Institute for Medical Research, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.24342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813564PMC
June 2013

Phase I study of sunitinib and erlotinib in advanced nonsquamous non-small cell lung cancer.

J Thorac Oncol 2011 May;6(5):951-3

Department of Medicine, Division of Hematology & Oncology, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31820db227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359645PMC
May 2011

Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies.

Invest New Drugs 2011 Apr 9;29(2):316-22. Epub 2009 Dec 9.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-009-9364-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038176PMC
April 2011

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors.

Cancer Chemother Pharmacol 2011 Feb 13;67(2):305-14. Epub 2010 Apr 13.

University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, 3103 WIMR, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1318-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050703PMC
February 2011

The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer patients.

Expert Opin Investig Drugs 2011 Feb 5;20(2):305-7. Epub 2011 Jan 5.

University of Wisconsin Comprehensive Cancer Center, Department of Human Oncology, Madison, Wisconsin, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.550873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303592PMC
February 2011

Initial clinical experience with stereotactic lung radiotherapy, based on a biological model-driven prescription method.

J Radiosurg SBRT 2011 ;1(3):221-229

Department of Medical Physics, Feinberg School of Medicine, Northwestern University, Evanston, IL.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725319PMC
January 2011

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study.

Cancer Chemother Pharmacol 2010 Sep 31;66(4):669-80. Epub 2009 Dec 31.

Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1209-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904454PMC
September 2010

A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.

Invest New Drugs 2010 Aug 13;28(4):509-15. Epub 2009 May 13.

Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin, K6/568 CSC, #5669, 600 Highland Avenue, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-009-9264-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032612PMC
August 2010

Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.

Head Neck 2010 May;32(5):599-606

Section of Hematology and Medical Oncology, University of Wisconsin, Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.21224DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028434PMC
May 2010

A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.

Invest New Drugs 2010 Feb 24;28(1):91-7. Epub 2009 Feb 24.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, K6/568 CSC, #5669, 600 Highland Avenue, Madison, WI, 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-009-9230-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045859PMC
February 2010

A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2009 May 13;63(6):1147-56. Epub 2008 Dec 13.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, 600 Highland Avenue, K6/568, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-008-0890-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050713PMC
May 2009

Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.

Lung Cancer 2009 Apr 12;64(1):51-9. Epub 2008 Aug 12.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164240PMC
April 2009

Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.

J Inorg Biochem 2008 Apr 30;102(4):693-8. Epub 2007 Oct 30.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, 600 Highland Avenue, Room K4/554, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinorgbio.2007.10.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390869PMC
April 2008

Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma.

Cancer 2006 Nov;107(10):2462-7

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22308DOI Listing
November 2006

Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.

J Thorac Oncol 2006 Sep;1(7):635-47

Department of Pharmacology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213-1863, USA.

View Article

Download full-text PDF

Source
September 2006

Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer.

J Thorac Oncol 2006 Sep;1(7):732-3; author reply 733

View Article

Download full-text PDF

Source
September 2006

Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond.

Lancet Oncol 2006 May;7(5):416-24

Division of Hematology/Oncology, University of California, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(06)70693-3DOI Listing
May 2006

Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.

J Thorac Oncol 2006 Mar;1(3):218-25

Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
March 2006

Systemic treatment of advanced non-small cell lung cancer.

Drugs Today (Barc) 2004 Aug;40(8):697-710

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
August 2004

Novel therapies for lung cancer.

Surg Oncol 2002 Dec;11(4):229-41

Department of Medicine, Medical Oncology, University of Wisconsin Medical School, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
December 2002

Adjuvant therapy in the treatment of non-small-cell lung cancer.

Clin Lung Cancer 2002 Nov;4(3):161-7

Section of Medical Oncology, Department of Medicine, University of Wisconsin Comprehensive Cancer Center, Madison 53792, USA.

View Article

Download full-text PDF

Source
November 2002